UNSPSC 51242209: Fluocinolone/lidocaine/neomycin/polymyxin

Fluocinolone/lidocaine/neomycin/polymyxin is a combination of drugs used for the treatment of external otitis.

UNSPSC 51242209 Fluocinolone/lidocaine/neomycin/polymyxin is a Commodity code that captures topical antimicrobial and anesthetic combination pharmaceuticals used in emergency medical services, forensic laboratory operations, and public health initiatives across state and local agencies, though recent state and local opportunities tagged to this code show minimal direct procurement activity aligned with the specific product formulation.

The recent opportunities in the source reflect fragmented activity across health departments, emergency services, and forensic laboratories rather than concentrated demand for this particular combination formulation. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually—a public health initiative focused on opioid response rather than the fluocinolone/lidocaine/neomycin/polymyxin combination. The City of Tucson Fire Department's RFP 260217 (posted June 24, 2026) solicited BLS and ALS pharmaceuticals and supplies with 251 line items covering glucometers, oxygen delivery equipment, IV administration sets, airway management devices, and medications for emergency medical services operations, but the scope does not isolate or emphasize the specific product code. Pinellas County, Florida's ITQ 26-0305-ITQ (posted April 23, 2026) procured 131 line items of certified reference materials for forensic drug analysis, including various drug standards for toxicology and seized drug analysis—a forensic laboratory use case distinct from clinical emergency or topical treatment applications. The remaining opportunities in the source (vendor forums, trade shows, networking events, and informational sessions) do not represent active procurements of pharmaceuticals or medical supplies. Geographic activity spans Florida (Seminole, Pinellas, and Indian River counties) and Arizona (Tucson), with no clear pattern of repeat buying or sustained demand concentration under this specific code. The mismatch between the code's nominal scope—a topical antimicrobial-anesthetic combination for wound or burn treatment—and the actual recent activity suggests this code sees limited direct procurement activity in state and local markets, or opportunities are being tagged with broader pharmaceutical family codes rather than this specific commodity formulation.